Literature DB >> 24170181

Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.

L Zhang1, M-M Xu, L Zeng, S Liu, X Liu, X Wang, D Li, R-Z Huang, L-B Zhao, Q-L Zhan, D Zhu, Y-Y Zhang, P Xu, P Xie.   

Abstract

Borna disease virus (BDV) is a non-cytolytic, neurotropic RNA virus that can infect a wide variety of vertebrate species from birds and primates to humans. Several studies have been carried out to investigate whether BDV is associated with neuropsychiatric diseases. However, this association is still inconclusive. Two panels of subjects consisting of 1,679 various neuropsychiatric patients and healthy people from three western China provinces were enrolled in this study. BDV p24 or p40 RNA in peripheral blood mononuclear cells (PBMCs) were detected in the first panel of 1,481 subjects using reverse transcription quantitative polymerase chain reaction (RT-qPCR) and cerebrospinal fluid (CSF) samples from the BDV RNA-positive individuals were subjected to BDV p24 antibodies testing by enzyme-linked immunosorbent assay (ELISA). BDV p24 or p40 RNA in PBMCs and p24 antibodies in plasma were detected in the second panel of 198 subjects by RT-qPCR and Western blot. A higher prevalence for BDV RNA was demonstrated in patients with viral encephalitis (6.70%), Guillain-Barré syndrome (6.70%), schizophrenia (9.90%) and chronic fatigue syndrome (CFS) (12.70%) compared to healthy controls in the first panel. CSF p24 antibodies were demonstrated in three viral encephalitis patients, two schizophrenia patients and two major depressive disorder (MDD) patients. The prevalences of p24 antibodies in plasma from patients with viral encephalitis (13.24%), multiple sclerosis (25.00%) and Parkinson's disease (22.73%) were significantly higher than healthy controls. This study demonstrates that BDV infection also exists in humans from three western China provinces, and suggests the involvement of the contribution of BDV in the aetiology of Chinese patients with some neuropsychiatric disorders, including viral encephalitis, schizophrenia, CFS, multiple sclerosis and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24170181     DOI: 10.1007/s10096-013-1996-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

1.  No serologic evidence of borna disease virus in patients with chronic fatigue syndrome.

Authors:  L Bode; A L Komaroff; H Ludwig
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

Review 2.  Borna disease virus - fact and fantasy.

Authors:  W Ian Lipkin; Thomas Briese; Mady Hornig
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

3.  Borna disease virus and neuropsychiatric disorders. The Japan Bornavirus Study Group.

Authors:  S Haga; Y Motoi; K Ikeda
Journal:  Lancet       Date:  1997-08-23       Impact factor: 79.321

4.  Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography.

Authors:  R Dürrwald; H Ludwig
Journal:  Zentralbl Veterinarmed B       Date:  1997-05

5.  Detection of Borna disease virus RNA from peripheral blood cells in schizophrenic patients and mental health workers.

Authors:  C H Chen; Y L Chiu; C K Shaw; M T Tsai; A L Hwang; K J Hsiao
Journal:  Mol Psychiatry       Date:  1999-11       Impact factor: 15.992

6.  Bornavirus closely associates and segregates with host chromosomes to ensure persistent intranuclear infection.

Authors:  Yusuke Matsumoto; Yohei Hayashi; Hiroko Omori; Tomoyuki Honda; Takuji Daito; Masayuki Horie; Kazuyoshi Ikuta; Kan Fujino; Shoko Nakamura; Urs Schneider; Geoffrey Chase; Tamotsu Yoshimori; Martin Schwemmle; Keizo Tomonaga
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

Review 7.  Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology.

Authors:  H Ludwig; L Bode
Journal:  Rev Sci Tech       Date:  2000-04       Impact factor: 1.181

8.  Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA.

Authors:  M Kao; A N Hamir; C E Rupprecht; Z F Fu; V Shankar; H Koprowski; B Dietzschold
Journal:  Vet Rec       Date:  1993-03-06       Impact factor: 2.695

9.  Detection of Borna disease virus-reactive antibodies from patients with affective disorders by western immunoblot technique.

Authors:  Z F Fu; J D Amsterdam; M Kao; V Shankar; H Koprowski; B Dietzschold
Journal:  J Affect Disord       Date:  1993-01       Impact factor: 4.839

10.  Prevalence of Borna disease virus RNA in peripheral blood mononuclear cells from blood donors.

Authors:  M Kishi; T Nakaya; Y Nakamura; M Kakinuma; T A Takahashi; S Sekiguchi; M Uchikawa; K Tadokoro; K Ikeda; K Ikuta
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

View more
  10 in total

1.  Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study.

Authors:  S-Y Tsai; T-Y Yang; H-J Chen; C-S Chen; W-M Lin; W-C Shen; C-N Kuo; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

2.  Real-time qPCR identifies suitable reference genes for Borna disease virus-infected rat cortical neurons.

Authors:  Lujun Zhang; Siwen Liu; Liang Zhang; Hongmin You; Rongzhong Huang; Lin Sun; Peng He; Shigang Chen; Hong Zhang; Peng Xie
Journal:  Int J Mol Sci       Date:  2014-11-26       Impact factor: 5.923

3.  Primary psychosis and Borna disease virus infection in Lithuania: a case control study.

Authors:  Violeta Zaliunaite; Vesta Steibliene; Liv Bode; Aurelija Podlipskyte; Robertas Bunevicius; Hanns Ludwig
Journal:  BMC Psychiatry       Date:  2016-11-03       Impact factor: 3.630

4.  Detection of Borna Disease Virus (BDV) in Patients with First Episode of Schizophrenia.

Authors:  Hasan Soltani; Serwa Mohammadzadeh; Manoochehr Makvandi; Siroos Pakseresht; Alireza Samarbaf-Zadeh
Journal:  Iran J Psychiatry       Date:  2016-10

5.  Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production.

Authors:  Simone Formisano; Mady Hornig; Kavitha Yaddanapudi; Mansi Vasishtha; Loren H Parsons; Thomas Briese; W Ian Lipkin; Brent L Williams
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats.

Authors:  Chenmeng Li; Xiaoyan Xu; Xiong Zhang; Ke Cheng; Yujie Guo; Jie Jie; Hua Guo; Yong He; Chanjuan Zhou; Siwen Gui; Xiaogang Zhong; Haiyang Wang; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-15       Impact factor: 2.570

7.  GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical Neurons.

Authors:  Siwen Liu; Liv Bode; Lujun Zhang; Peng He; Rongzhong Huang; Lin Sun; Shigang Chen; Hong Zhang; Yujie Guo; Jingjing Zhou; Yuying Fu; Dan Zhu; Peng Xie
Journal:  Int J Mol Sci       Date:  2015-08-17       Impact factor: 5.923

8.  The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets.

Authors:  Zi Li; Wenqi He; Yungang Lan; Kui Zhao; Xiaoling Lv; Huijun Lu; Ning Ding; Jing Zhang; Junchao Shi; Changjian Shan; Feng Gao
Journal:  PeerJ       Date:  2016-09-15       Impact factor: 2.984

9.  Knock-Down of Endogenous Bornavirus-Like Nucleoprotein 1 Inhibits Cell Growth and Induces Apoptosis in Human Oligodendroglia Cells.

Authors:  Peng He; Lin Sun; Dan Zhu; Hong Zhang; Liang Zhang; Yujie Guo; Siwen Liu; Jingjing Zhou; Xiaoyan Xu; Peng Xie
Journal:  Int J Mol Sci       Date:  2016-03-24       Impact factor: 5.923

10.  Different inhibitory effects on the proliferation and apoptosis of human and laboratory Borna disease virus‑infected human neuroblastoma SH‑SY5Y cells in vitro.

Authors:  Hua Huang; Hong Zhang; Dan Li; Shigang Chen; Chanjuan Zhou; Qi Li; Peng He; Liang Fang; Yong Zhang; Xiaomei Li; Jingjing Zhou; Lin Sun; Siwen Liu; Yujie Guo; Ying Huang; Peng Xie
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.